Narrative review: the promotion of gabapentin: an analysis of internal industry documents.
about
Ghostwriting at elite academic medical centers in the United StatesThe cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United StatesGhost authorship in industry-initiated randomised trialsReporting bias in medical research - a narrative reviewThe imperative to share clinical study reports: recommendations from the Tamiflu experienceIndustry sponsorship and research outcomeIndustry sponsorship and research outcomeThe cycle of bias in health research: a framework and toolbox for critical appraisal trainingPartisan perspectives in the medical literature: a study of high frequency editorialists favoring hormone replacement therapy.Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trialImplementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigationCharacteristics and impact of drug detailing for gabapentinPharmacotherapy of schizophrenic patients: preponderance of off-label drug useOff-label promotion, on-target salesObesity, the endocannabinoid system, and bias arising from pharmaceutical sponsorshipConflicts of interest at medical journals: the influence of industry-supported randomised trials on journal impact factors and revenue - cohort studyStrategies and practices in off-label marketing of pharmaceuticals: a retrospective analysis of whistleblower complaintsPharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012Who has used internal company documents for biomedical and public health research and where did they find them?Strategies for obtaining unpublished drug trial data: a qualitative interview studyThe citalopram CIT-MD-18 pediatric depression trial: Deconstruction of medical ghostwriting, data mischaracterisation and academic malfeasance.Commercial influence and learner-perceived bias in continuing medical education.Off-label prescribing: a call for heightened professional and government oversightKnowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research.Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.Public health and the knowledge industry.Challenging medical ghostwriting in US courts.Of sophists and spin-doctors: industry-sponsored ghostwriting and the crisis of academic medicine.Prescribers' and Organizational Leaders' Preferences for Education about Heavily Marketed DrugsPrescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07Chronological changes in Japanese physicians' attitude and behavior concerning relationships with pharmaceutical representatives: a qualitative study.Ghost- and guest-authored pharmaceutical industry-sponsored studies: abuse of academic integrity, the peer review system, and public trust.Investigator experiences with financial conflicts of interest in clinical trials.The rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009.How basic scientists help the pharmaceutical industry market drugs.Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.Perceptions and Attitudes of Egyptian Health Professionals and Policy-Makers towards Pharmaceutical Sales Representatives and Other Promotional ActivitiesPrevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.On Ghosts and Other Unwelcome Guests
P2860
Q21090130-AC82605F-DC75-4ECA-B772-C73AB6BE48ABQ21090138-0EDD5C09-FEED-40A3-9A1E-695EC8C812ABQ21144680-7FFCA88F-2F5D-4BED-AC17-78E2E1FFBB41Q21203744-91C1C422-3BFB-4D63-ABC1-D6C2F142B4E5Q21563018-D1814820-2E20-4EF9-BB91-D3188F98A955Q24202591-D2D558AB-12F3-4A81-AA74-1FB01D99B57AQ24234843-C6C999C1-0CA9-40DD-8559-4805BC915553Q24289237-88010629-08B8-4CBA-AFAE-BA2D8D7CD6ABQ24289488-779A6CF1-5E43-4493-9C62-272B2CF105F7Q24604806-B6EA0CA4-295E-451C-82A7-8124664E8313Q27498844-26DC6905-879C-4A0F-9DBE-E4CDDCA7F8DCQ28469192-00A81F5C-F011-4C5B-8F16-812409AD7A70Q28473574-08FB6AF1-59D6-474D-AD64-AB5A04E8A991Q28473977-74E285E1-5080-464B-BBD1-100035D98954Q28475155-C05FD357-9A9F-409E-97D5-894C4A4E762EQ28475928-BBE9C3D9-5996-4439-B97F-E79BA59875EDQ28477644-55829294-0CD8-4B9C-95A5-3DF3253E6EA4Q28552890-D940121F-A905-4244-B1AD-1E8986999D0FQ28657906-4107D5C0-3395-4D73-A16B-63C44D529839Q28681320-327D140E-8090-42F8-96EB-225896555DF3Q31095928-FEB26DED-089A-4B7D-8787-BA7EE2533FA5Q33568849-2152A13B-BB88-4F8F-B257-9A51DFB2BD1DQ33720862-E731FE47-8800-4C4E-B408-3D3DC3559B60Q33807895-C26820FF-5C0F-480D-BFA8-2CF46BFE18DEQ33851285-B75EE93F-9E52-4939-8D62-CFC0ED5E14E3Q34089418-365469FC-9D7B-4FA5-8AE5-1071BB297333Q34145613-6D7D016E-AD39-4FAC-9467-6D1C79A1AFE5Q34165083-0A18E75F-F86E-4A54-8861-E25D28B7B3DBQ34167838-238D3B97-C260-4F5C-92F0-44272B63A07FQ34180457-46C82699-4F78-4D9C-9675-84DCBA00DE36Q34215520-BDD69669-6EF9-4D91-800A-433637FDB4E8Q34339237-0D44B419-FDDD-4119-A0CD-07852FFB9B62Q34540824-62D0919E-C69D-4CAC-92FE-47B55CF2E4D6Q34617315-DEB02513-1F4C-4309-8BA8-39F377C3227AQ34965263-8B9B404E-64A3-4B32-B4D5-1AB863AFE648Q35047976-D42411DF-45B0-45AE-BAC8-F2F476EAA664Q35684841-4D64DB88-1A69-4380-8874-B7D58A2E0B55Q35810078-2D31A0C3-7EA5-4C40-8826-201C42486C77Q35907148-83515A85-3092-4FE9-923D-C4564092CAA5Q36083903-C9D6BC6D-D155-4EFE-98D6-4573F20E0177
P2860
Narrative review: the promotion of gabapentin: an analysis of internal industry documents.
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Narrative review: the promotio ...... f internal industry documents.
@ast
Narrative review: the promotio ...... f internal industry documents.
@en
Narrative review: the promotio ...... f internal industry documents.
@nl
type
label
Narrative review: the promotio ...... f internal industry documents.
@ast
Narrative review: the promotio ...... f internal industry documents.
@en
Narrative review: the promotio ...... f internal industry documents.
@nl
prefLabel
Narrative review: the promotio ...... f internal industry documents.
@ast
Narrative review: the promotio ...... f internal industry documents.
@en
Narrative review: the promotio ...... f internal industry documents.
@nl
P2093
P1476
Narrative review: the promotio ...... f internal industry documents.
@en
P2093
C Seth Landefeld
Mary-Margaret Chren
Michael A Steinman
P304
P356
10.7326/0003-4819-145-4-200608150-00008
P407
P50
P577
2006-08-01T00:00:00Z